Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression
SAD
1 other identifier
interventional
292
2 countries
9
Brief Summary
The purpose of this study is to determine if the use of pedometers can help depressive inpatients in psychiatric clinics to increase their level of physical activity. Therefore patients are given a pedometer and instructions how to raise their level of daily steps. Intervention group is compared with a control group that is receiving treatment-as-usual. The intervention is hypothesized to increase number of daily steps and have positive effects on mood, depression and anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Jul 2016
Typical duration for not_applicable depression
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 22, 2016
CompletedFirst Posted
Study publicly available on registry
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedSeptember 1, 2021
August 1, 2021
3.5 years
July 22, 2016
August 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in average number of steps per day
Number of steps per day is objectively measured using accelerometry (ActiGraph GT1M)
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in depressive symptoms - clinician rated
Depressive symptoms are rated by a blind study employee using MADRS
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Secondary Outcomes (13)
Change in physical activity - subjective
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in physical activity - objective
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in psychopathological symptoms
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in health-related quality of life
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
Change in depressive symptoms
From baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)
- +8 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALPatients receive a pedometer and instructions how to raise their physical activity
Control group
NO INTERVENTIONPatients receive treatment-as-usual
Interventions
Patients receive a pedometer with instructions how to raise their number of daily steps
Eligibility Criteria
You may qualify if:
- Major Depression, moderate to severe as main diagnosis
- Inpatient status
- Prospected inpatient treatment of at least 4 weeks
- Able to understand german
You may not qualify if:
- Physical disease or disability that makes it impossible to reach the goal 5000 steps per day
- Borderline personality disorder
- Bipolar Disorder
- Schizophrenia
- Anorexia Nervosa
- Dementia
- Psychotic Depression
- Pregnancy
- Acute suicidality
- Substance dependancies with actual consumption (except nicotine)
- Current pedometer-use
- More than 10.000 steps per day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charite University, Berlin, Germanylead
- Robert-Enke-Stiftungcollaborator
Study Sites (9)
Paracelsus University Salzburg - Clinic for Psychiatry and Psychotherapy
Salzburg, 5020, Austria
Ludwig Maximilian University Munich - Clinic for Psychiatry and Psychotherapy
Munich, Bavaria, 80366, Germany
Oberhavel Clinics GmbH - Clinic for Psychiatry, Psychosomatics and Psychotherapy
Hennigsdorf, Brandenburg, 16761, Germany
Health Center Odenwaldkreis GmbH - Center for Mental Health
Erbach im Odenwald, Hesse, 64711, Germany
University of Frankfurt/Main - Clinic for Psychiatry, Psychosomatic and Psychotherapy
Frankfurt am Main, Hesse, 60528, Germany
University of Göttingen - Clinic for Psychiatry and Psychotherapy
Göttingen, Lower Saxony, 37075, Germany
University RWTH Aachen, Clinic for Psychiatriy, Psychotherapy and Psychosomatic
Aachen, North Rhine-Westphalia, 52074, Germany
Ev.Luth. Diakonissenanstalt Flensburg - Clinic for Psychiatry, Psychosomatic and Psychotherapy
Flensburg, Schleswig-Holstein, 24939, Germany
Charité Universitätsmedizin Berlin - Departement of Psychiatry
Berlin, 10117, Germany
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Ströhle, Prof.Dr.
Charité Universitätsmedizin Berlin - Klinik für Psychiatrie und Psychotherapie
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med.
Study Record Dates
First Submitted
July 22, 2016
First Posted
August 1, 2016
Study Start
July 1, 2016
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
September 1, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share